Nina Grossmann1, Ahmet S Vakkasoglu2, Sabine Hulpke1, Rupert Abele1, Rachelle Gaudet2, Robert Tampé3. 1. Institute of Biochemistry, Biocenter, Goethe-University Frankfurt, Max-von-Laue-Street 9, D-60438 Frankfurt/M., Germany. 2. Department of Molecular and Cellular Biology, Harvard University, 52 Oxford Street, Cambridge, Massachusetts 02138, USA. 3. 1] Institute of Biochemistry, Biocenter, Goethe-University Frankfurt, Max-von-Laue-Street 9, D-60438 Frankfurt/M., Germany [2] Cluster of Excellence Frankfurt-Macromolecular Complexes, Goethe-University Frankfurt, Max-von-Laue-Street 9, D-60438 Frankfurt/M., Germany.
Abstract
The ATP-binding cassette (ABC) transporter associated with antigen processing (TAP) participates in immune surveillance by moving proteasomal products into the endoplasmic reticulum (ER) lumen for major histocompatibility complex class I loading and cell surface presentation to cytotoxic T cells. Here we delineate the mechanistic basis for antigen translocation. Notably, TAP works as a molecular diode, translocating peptide substrates against the gradient in a strict unidirectional way. We reveal the importance of the D-loop at the dimer interface of the two nucleotide-binding domains (NBDs) in coupling substrate translocation with ATP hydrolysis and defining transport vectoriality. Substitution of the conserved aspartate, which coordinates the ATP-binding site, decreases NBD dimerization affinity and turns the unidirectional primary active pump into a passive bidirectional nucleotide-gated facilitator. Thus, ATP hydrolysis is not required for translocation per se, but is essential for both active and unidirectional transport. Our data provide detailed mechanistic insight into how heterodimeric ABC exporters operate.
The ATP-binding cassette (ABC) transporter associated with antigen processing (TAP) participates in immune surveillance by moving proteasomal products into the endoplasmic reticulum (ER) lumen for major histocompatibility complex class I loading and cell surface presentation to cytotoxic T cells. Here we delineate the mechanistic basis for antigen translocation. Notably, TAP works as a molecular diode, translocating peptide substrates against the gradient in a strict unidirectional way. We reveal the importance of the D-loop at the dimer interface of the two nucleotide-binding domains (NBDs) in coupling substrate translocation with ATP hydrolysis and defining transport vectoriality. Substitution of the conserved aspartate, which coordinates the ATP-binding site, decreases NBD dimerization affinity and turns the unidirectional primary active pump into a passive bidirectional nucleotide-gated facilitator. Thus, ATP hydrolysis is not required for translocation per se, but is essential for both active and unidirectional transport. Our data provide detailed mechanistic insight into how heterodimeric ABC exporters operate.
Life depends on transport systems that shuttle ions and molecules across cell membranes.
ATP-binding cassette (ABC) transporters, which represent the largest family of primary
active transporters, convert the energy of ATP binding and hydrolysis via two NBDs into conformational changes of
two transmembrane domains and thus move a wide range of essential as well as harmful
substrates across membranes12345. In humans, ABC transporters
participate in a wide range of important cellular processes such as chloride homeostasis,
cholesterol and lipid metabolism,
insulin secretion, detoxification and adaptive immunity. Accordingly, ABC transporter
malfunction is linked to many pathological conditions, including cystic fibrosis, diabetes,
adrenoleukodystrophy, multidrug resistance, neurological and infectious diseases6.The ABCtransporter associated with antigen processing (TAP) plays a prime role in adaptive
immunity by supplying proteasomal degradation products for loading of major
histocompatibility (MHC) class I molecules in the ER lumen. This sophisticated peptide
loading process is accomplished by a macromolecular complex composed of TAP, tapasin, calreticulin, ERp57 and
MHC I (refs 7, 8, 9). Loaded MHC I molecules then traffic to the cell surface to present their
antigenic cargo to CD8+ cytotoxic T cells for immune surveillance, detection
and elimination of abnormalities such as virally or malignantly transformed cells.TAP consists of two ABC half-transporters, TAP1 and TAP2, each
composed of a transmembrane domain (TMD) followed by an NBD5. The two NBDs
are thought to run through a cycle of dimer formation and dissociation controlled by
ATP binding and hydrolysis,
respectively, which in turn drives the TMDs from an inward- to an outward-facing
conformation and back101112. The communication between the TMDs and NBDs
is mediated by interactions between two coupling helices found in each TMD and conserved
regions of the NBDs1013. The NBDs contain conserved motifs with distinct
functions in ATP binding and hydrolysis.
Interestingly, the two composite ATP-binding sites are functionally non-equivalent. The
Walker A and B motifs of TAP2 and the
C-loop of TAP1 form the active
ATP-binding site II (Fig. 1a), whereas the degenerate ATP-binding
site I displays a very low ATPase activity14151617.
Figure 1
A D-loop mutation in TAP1
enables antigen peptide export without ATP hydrolysis.
(a) Two asymmetric ATP-binding sites are formed at the NBD dimer interface
of TAP1 (cyan) and
TAP2 (green). The conserved
aspartate in each D-loop
contributes to the degenerate site I and consensus site II formed by the Walker A
and B of the opposite subunit. The NBD interface is modelled on the TAP1-NBD dimer (PDB 2IXE)17. The electrostatic and hydrogen bond network of the active site II is enlarged
in the lower panel. Key amino-acid residues, ATP and Mg2+ (sphere) are illustrated.
(b) Transport of fluorescein-labelled peptide
RRYQNSTC(FL488)L (1 μM) across ER membranes
containing equal amount of wt TAP and D-loop variants was analysed in the presence
of ATP, ADP (3 mM each) or 200-fold molar
excess of unlabelled competitor peptide plus ATP for 3 min. Transported peptides were quantified
fluorometrically. Data are normalized to wt TAP and presented as means±s.d.
(n=3). Equal expression levels of TAP1 and TAP2 were confirmed by immunoblotting. (c) MHC class I
antigen processing was established by expressing wt TAP (black) or the D674A/wt
complex (orange) in the presence of tapasin and MHC I (HLA-B*4402). MHC I surface expression was
monitored by flow cytometry using the conformation-specific anti-HLA-A/B/C
antibody W6/32. The absence of TAP1 (blue) or MHC I (grey) resulted in a suppression of MHC I
surface expression or background level, respectively.
The D-loop is the second hallmark found in all ABC transporters, besides the signature
C-loop essential for ATP hydrolysis.
However, the function of this conserved ‘SALD’ sequence motif is not well
characterized and contradictory results exist. In SUR1, substitution of the aspartate by a cysteine in one of the NBDs interferes with the gating of the associated
Kir6.2 channel18. On
the other hand, exchange of the D-loop aspartate to alanine
in the sterol transporter ABCG5/8 had no
impact on sterol transport in vivo19. In the homodimeric lipid A
exporter MsbA, substitution of the conserved aspartate to glycine
strongly interferes with bacterial viability20. In ATP-bound NBD dimers, the two D-loops contact one
another at the dimer interface (Fig. 1a) and position the Walker A
motif and H-loop of the opposite NBD via a complex hydrogen bond and electrostatic
network2122. Moreover, the D-loop and Walker B motifs position,
coordinate and activate the putative attacking water for ATP hydrolysis1723. By forming contacts with the
ATP-binding sites in cis and trans, the D-loops are in a prime position to
mediate communication between both ATPase sites.Despite the important task of TAP in immune surveillance, fundamental questions regarding
antigen translocation by TAP, questions that are also relevant to other ABC export systems,
remain to be answered: (i) Can the TAP complex pump peptide substrates against a
concentration gradient? (ii) Does TAP operate uni- or bidirectionally? (iii) What
determines its directionality? Previous studies in semi-permeabilized cells or isolated
microsomes relied on the trapping of translocated peptides into the ER lumen by
glycosylation to prevent export from the ER24, making it impossible to
tackle these questions. Moreover, determining the concentration of free peptide in the ER
lumen is important to understand peptide editing and selection of immunodominant epitopes.
These questions are also difficult to address in other well-studied ABC transporters, many
of which transport hydrophobic substrates that partition to some extent within the lipid
bilayer. To the best of our knowledge, the only report of substrate accumulation against a
concentration gradient for an ABC exporter is that of P-gp (ABCB1), where
tenfold substrate accumulation has been estimated25. Furthermore, the
directionality of transport was challenged by the observation that a bacterial homologue of
P-gp may function as ATP synthase at
the expense of drug transport in the reverse direction26.To address these questions, fundamental to the function of primary transporters, we
reconstituted TAP in proteoliposomes and performed influx and efflux assays. We demonstrate
that TAP accumulates peptides in a unidirectional manner to a threshold concentration
determined by trans-inhibition. Transport unidirectionality and the generation of a
concentration gradient are coupled to ATP
hydrolysis as we have identified a specific D-loop mutant inactive in ATP hydrolysis, which functions as a
nucleotide-gated facilitator. Furthermore, this mutation has only a minor impact on
ATP and peptide binding. Using ratTAP1 NBD homodimerization as a model
system for biophysical measurements and structural studies, we showed that the D-loop
mutation decreases the ATP-driven NBD
dimerization affinity by nearly an order of magnitude and affects NBD dimer structure in
subtle ways. We combine our biochemical, biophysical and structural data to propose a model
in which peptide release to the lumenal side is a checkpoint for ATP hydrolysis, thus making ATP hydrolysis the key step in unidirectional
peptide transport.
Results
D-loop mutation enables translocation without ATP hydrolysis
We focused our mechanistic studies on the D-loops of TAP, whose functions are
ill-defined. By scanning mutagenesis, we analysed first the D-loop of TAP1, which forms part of the active
ATP-binding site II (Supplementary Fig.
1). Similar to wild-type (wt) TAP, all D-loop mutants showed ATP-dependent peptide transport activity (Supplementary Fig. 2a). Surprisingly, the
D674A/wt complex translocates peptides not only in the presence of ATP but also of ADP (Fig. 1b).
ADP binds to TAP with a similar
affinity to that of ATP but cannot
energize peptide transport of wt TAP272829. Interestingly, the
corresponding D-to-A mutation in TAP2 (wt/D638A), affecting the degenerate ATP-binding site I,
behaves like wt TAP. In contrast, the double D-loop mutant D674A/D638A is inactive in
peptide transport. It is worth noting that all mutants displayed similar affinity for
peptides and ATP as compared with
wt TAP (Supplementary Table 1).We also addressed the physiological consequences of the surprising D-loop
substitution. To this end, the pathway of MHC I antigen processing was reconstituted
in insect cells lacking the components of this pathway. The cell surface expression
of the MHC I allele B*4402 was monitored by flow cytometry (Fig.
1c). Expression of wt TAP and D674A/wt mutant leads to a similar upshift in
MHC I cell surface expression, whereas the lack of TAP1 impairs MHC I antigen presentation. These results indicate
that the energetically uncoupled D674A/wt complex promotes antigen processing and MHC
I presentation to the same extent as wt TAP.
D-loop enables coupling of transport and hydrolysis
To explore the molecular mechanism of antigen translocation, wt TAP and the D674A/wt
complex were purified and functionally reconstituted in proteoliposomes. Peptide
translocation by wt TAP is strictly ATP dependent, whereas the D674A/wt TAP mediated peptide
translocation even in the presence of ADP or non-hydrolysable adenosine 5′-(β,γ-imido)triphosphate
(AMPPNP) (Fig.
2a). Notably, both wt TAP and D674A/wt need Mg2+ ions for
peptide translocation (Supplementary Fig.
2b). Also, wt and D674A/wt TAP showed the same binding properties for
ATP, ADP (Fig. 2b) and
peptides (Supplementary Table 1).
Consistent with these data on full-length humanTAP, a fluorescence
polarization-based competition assay showed that the affinities for ATP and ADP of isolated wt and D-loop (D651A) mutant ratTAP1-NBD are similar (Supplementary Table 2). Furthermore, the
Michaelis–Menten kinetics for peptide transport by wt TAP and D674A/wt are
equal (Fig. 2c, Supplementary Fig. 2c and Supplementary Table 3), confirming that the affinity for ATP and peptides is not affected by the D-loop
substitution.
Figure 2
The D-loop controls the allosteric coupling between peptide transport and
ATP hydrolysis.
(a) Transport of fluorescein-labelled peptide
RRYC(FL488)KSTEL (1 μM) by reconstituted TAP
(1.1 μg initial amount) was analysed for 10 min in the
presence of different nucleotides (3 mM each) or ATP in the presence of a 200-fold excess
of unlabelled peptide (comp.). (b) Purified wt TAP or the D674A/wt complex
(0.5 μM each) was incubated with 8-azido-[α-32P]-ATP (1 μM)
in the absence or presence of a 200-fold excess of ATP or ADP. Cross-linked products were separated by SDS–PAGE
(6%) and visualized by autoradiography. *Tapasin-TAP2
fusion used to separate the TAP subunits40. (c)
ATP-dependent peptide
transport was analysed in the presence of RRYC(FL488)KSTEL
(1 μM). (d) Hydrolysis of ATP (3 mM) by purified TAP variants (0.5 μM
each) was analysed for 20 min in the presence (black) or absence (white) of
peptide RRYQKSTEL (1 μM). An ATPase inactive TAP complex (3xKO) with
a triple mutation in the Walker A of TAP1 and TAP2 (K544A and K509A, respectively) and H-loop of
TAP2 (H661A) was used as
control to measure TAP-independent residual ATPase activity30. Data
are normalized to wt TAP and presented as means±s.d. (n=3).
We next analysed the coupling between peptide translocation and ATP hydrolysis. As shown in Fig. 2d, peptide-stimulated ATP hydrolysis by wt TAP was observed. Notably, TAP has no basal
ATPase activity as concluded from a comparison with an ATPase inactive mutant
(3xKO)30. In contrast to wt TAP, the D674A/wt complex is inactive
in ATP hydrolysis, either in the
presence or absence of peptide substrate. Consistently, mutating the D-loop of the
isolated ratTAP1-NBD also impairs
its ATPase activity (Supplementary Fig.
3). Therefore, peptide transport still occurs despite impairments in
ATP hydrolysis, indicating that
the crosstalk between peptide translocation and ATP hydrolysis is disrupted.
Active exporter turned into a nucleotide-gated facilitator
We then examined the kinetics and energetics of antigen translocation. Over time, wt
TAP transports peptides to much higher levels than the D674A/wt complex (Fig. 3a). However, the initial translocation rate constants
(zero-trans flux) of wt TAP and D674A/wt were comparable at 11.1±1.0 and
10.1±0.8 nmol min−1 mg−1,
respectively, implying that the rate of conversion from the inward- to the
outward-facing conformation does not depend on ATP hydrolysis. Unfortunately, loss of TAP activity prevented
observations over incubation times longer than 1 h. Quantification of the
lumenal concentration revealed that if 1 μM of peptide was added
externally, wt TAP accumulated peptides to 8.3±0.6 μM, whereas
D674A/wt reached 0.9±0.3 μM (Fig. 3b). At low
concentration of peptides added (0.1 μM), a 38-fold accumulation was
observed for wt TAP, whereas the D674A/wt complex equilibrated at
0.1 μM. These experiments prove for the first time that TAP uses the
chemical energy of ATP to pump
peptides against the concentration gradient. In stark contrast, the D-loop mutation
disrupts the tight coupling between peptide translocation and ATP hydrolysis, allowing only for a passive
peptide flux, which still requires binding of ADP or ATP.
Figure 3
TAP is an active peptide export pump, whereas D674/wt is a facilitator.
(a) Time-dependent peptide transport of reconstituted wt TAP and D674A/wt
complex (1.1 μg initial amount each) was followed in the presence of
peptide RRYC(FL488)KSTEL (1 μM) and ATP (3 mM). Data are normalized to
the transported peptide by wt TAP after 1 h. (b) The concentration
of peptides accumulated by wt or D674A/wt TAP was analysed after 1 h at
different concentrations of external Atto633-labelled peptide
RRYC(AT633)KSTEL. The internal volume of the liposomes was
quantified by encapsulated 5(6)-carboxyfluorescein. The red line reflects a
lumenal-to-external peptide ratio (L/E) of 1 (passive flux). The dashed red line
illustrates trans-inhibition at ~16 μM. The inset shows the
curves and fit in the low peptide concentration range.
Trans-inhibition at high lumenal substrate concentration
Notably, at high substrate concentrations, for example, 100 μM, the
translocated peptides did not reach above 16 μM in the liposomes for wt
TAP and D674A/wt, ruling out that the D-loop mutation converts the transporter into a
channel. Furthermore, these results are not affected by the amount of TAP
reconstituted per liposome (Supplementary Fig.
4). Also, single vesicle-based translocation assays show that more than 95%
of the proteoliposomes are transport active, establishing that each liposome contains
at least one active transport complex. An initial lipid-to-TAP (w/w) reconstitution
ratio of 20 leads to approximately 300,000 lipids per active and correctly oriented
TAP complex, ensuring that peptide accumulation is not underestimated by low
reconstitution efficiency (Supplementary Fig.
5). These data indicate that TAP is inhibited in trans by accumulated
lumenal peptide. Because of active transport by wt TAP, trans-inhibition is reached
at a much lower external peptide concentration than for the D-loop mutant. Because
substrate translocation in the D674A/wt complex is uncoupled from ATP hydrolysis, the measured EC50
can be attributed to a low-affinity peptide-binding site, exposed to the vesicle
lumen, with a Kd of 10.7±0.5 μM. It is worth
noting that peptide transport is not inhibited by proton or ion gradients, because
nigericin or valinomycin did not affect the transport
activity either of wt TAP or D674A/wt (Supplementary Fig. 6). These results provide direct evidence that TAP
operates as primary active transporter, which is inhibited by saturating a
low-affinity binding site that is accessible from the ER lumen. We propose that this
trans-inhibition process is important for a fine-tuned balance between antigen
processing and ER homeostasis, thereby preventing a harmful accumulation of peptides
in the ER and induction of ER stress31.
ATP hydrolysis mediates
unidirectional/vectorial transport
Membrane transport via alternating access can occur either uni- or bidirectionally.
We therefore analysed the vectoriality by dual-colour import/export assays (Fig. 4a). Peptides were labelled by spectrally separated
fluorophores, which affect neither their binding affinities nor transport
kinetics32. First, the translocation of Atto565-labelled peptides
was recorded. After washing, a second transport period was initiated under the same
conditions by adding the fluorescein-labelled peptide. By parallel detection of both
peptides, we observed that initially transported peptides were not retrotranslocated
by wt TAP (Fig. 4b and Supplementary Fig. 7), as also established by observing the uptake of the
differently labelled peptides over time during the second transport period (Fig. 4c). If retrotranslocation occurred, a decrease of
Atto565-labelled peptide would be observed because re-uptake would be competed by the
large excess of fluorescein peptide in the second transport period. On the contrary,
the D674A/wt complex facilitated the retrotranslocation of initially translocated
Atto565-labelled peptides at the expense of the fluorescein-labelled peptides,
whereas the total lumenal peptide concentration remained constant (Fig. 4c,d). Counter-flow experiments with proteoliposomes prefilled with
fluorescein-labelled peptides demonstrated that peptide influx and efflux by D674A/wt
are not coupled but require ATP
(Supplementary Fig. 7). In
conclusion, wt TAP operates unidirectionally, even if the proteoliposomes contain
saturating concentrations of peptide, whereas the D-loop mutant acts as a
nucleotide-gated facilitator allowing for passive (downhill) flux in both
directions.
Figure 4
The D-loop sets the directionality of antigen translocation.
(a) Vectoriality of antigen translocation by TAP was demonstrated by
dual-colour transport assays with Atto565 (red)- and fluorescein (green)-labelled
peptides (RRYQNSTC(AT565)L and RRYQNSTC(FL488)L,
respectively). (b–d) After the first 10-min translocation of
RRYQNSTC(AT565)L (1 μM; initial TAP amount for
reconstitution 1.4 mg) and subsequent washing, a second transport reaction was
performed with RRYQNSTC(FL488)L (1 μM) for
10 min; b) or followed over time (c,d). In b,
amount of Atto565-labelled peptide encapsulated in the lysosomes after first (1st)
and second (2nd) transport is depicted, whereas in c,d show the
amounts of Atto565-labelled (red), fluorescein-labelled (green) and total peptide
(black) in the lumen of liposomes after different time points of the second
transport process. Data are normalized to the first transport reaction of wt TAP
and are presented as means±s.d. (n=3).
The D-loop influences the affinity for NBD dimerization
To understand the D-loop substitution at a biochemical and structural level, we used
a model system relying on homodimerization of the isolated ratTAP1-NBD17. This model system
enables structural studies of NBD dimers as well as biophysical measurements of NBD
dimerization affinities that are not accessible in full-length transporter systems.
Importantly, the hydrolysis-deficient Walker B mutant (D645N) has a D-loop structure
and interactions very similar to those seen in physiological NBD dimer
structures17233334. We introduced the D-loop D651A mutation
in this model system, which is equivalent to D674A in humanTAP1, to study its effect on NBD dimerization,
yielding two copies of the D-loop mutation in the homodimeric state. It should be
noted that no heterodimeric ABC transporter or isolated NBDs in the fully closed
state have been assembled and structurally analysed so far. Our homodimeric model
system, although imperfect, does enable us to measure the impact of the D-loop
mutation on dimerization. We determined the dissociation constant
(Kd) of the NBD dimer using analytical ultracentrifugation. As
observed in sedimentation velocity experiments, sedimentation coefficient
distributions displayed two populations, corresponding to NBD monomer and dimer
(Fig. 5 and Table 1). The
hydrolysis-deficient Walker B mutant was predominantly dimeric only in the presence
of ATP, whereas in the presence of
ADP the monomeric form was
dominant. In contrast, the Walker B/D-loop double mutant is mostly monomeric
regardless of the nucleotide present. Kds obtained from
sedimentation equilibrium experiments (Table 1) confirm the
sedimentation velocity results, and indicate ~8-fold decreased affinity of NBD
dimerization for the double mutant TAP1-NBD in the presence of ATP, yielding a Kd similar to that in the
presence of ADP. In summary, these
results demonstrate that the ratTAP1-NBD dimerizes in an ATP-dependent manner, and that the D-loop substitution (present at
both ATPase sites in this model system) essentially eliminates the increased affinity
observed in the presence of ATP. In
the context of the full-length transporter, a reduction of the affinity for NBD
dimerization would not prevent, but would destabilize the outward-facing
conformation.
Figure 5
The D-loop D-to-A substitution greatly reduces ATP-driven NBD dimerization.
(a,b) Sedimentation coefficient distributions derived from
sedimentation velocity experiments. Distributions for Walker B D645N (black
traces) and Walker B D645N/D-loop D651A (cyan traces) rat TAP1-NBD are shown in ATP (a) or ADP (b) containing buffer. Peaks
are labelled ‘monomer’ and ‘dimer’ based on the
calculated molecular weights (see Table 1).
Table 1
Data analysis for sedimentation experiments.
Mutant
Nucleotide
Sedimentation velocity
Sedimentation equilibrium
Molecular weight in kDa
2nd/1st ratio
Kdfor dimerization (μM)*
1st Peak
2nd Peak
Walker B
ATP
28.0 (1.14)†
47.3 (2.97)†
2.61
22.4 (0.8)‡
Walker B/D-loop
ATP
28.6 (3.22)
50.7 (0.37)
0.11
170 (0.9)
Walker B
ADP
25.1 (1.20)
47.3 (0.82)
0.68
111 (0.9)
Walker B/D-loop
ADP
30.8 (1.97)
54.6 (0.52)
0.26
164 (1.0)
For the sedimentation velocity experiments, we list the molecular
weights from best fits of the distributions. The ratio of integration
of the two peaks is a measure of the ratio of dimer to monomer
populations. For the sedimentation equilibrium experiments, we list
the TAP1-NBD
dimerization constants obtained.
*Ninety-five percent confidence intervals are as
follows: Walker B D645N+ATP or ADP, 22.1–23.21 or 56–187,
respectively; and Walker B D645N/D-loop D651A+ATP or ADP, 103–118 or
156–174, respectively.
†Numbers in parentheses correspond to the
integration of each peak shown in Fig. 5.
‡Numbers in parentheses are the global
χ2 values.
D-loop mutation subtly alters the NBD dimer structure
To visualize the structural changes caused by the D-loop substitution, we determined
the crystal structure of Walker B/D-loop double mutant ratTAP1-NBD (Table 2).
Interestingly, a dimer is observed through crystallographic twofold symmetry,
revealing that although dimerization affinity is diminished, the double mutant can
form the canonical NBD sandwich interface. Comparison with the previously determined
Walker B mutant structure17, which contains an entire dimer in the
asymmetric unit, reveals two significant differences. First, there is a global twist
of the two protomers along the dimer interface (Fig. 6a and
Supplementary Movie 1). Although the
two ATPs and their binding sites are essentially unaffected by this structural
re-organization, the C-terminal regions slide with respect to each other. Second,
although the D-loop and interacting Walker A positions are essentially unaffected
despite the loss of several hydrogen bonds (see below and Fig.
6b,c and Supplementary Fig.
8), the D-loop shows evidence of increased flexibility. A closer look at the
TAP1-NBD structure reveals two
key interactions for the D-loop aspartate. First, it interacts with the backbone of Walker A
asparagine (N517) from the other protomer, a γ-phosphate sensor for the bound
nucleotide35. Second, the D-loop aspartyl side chain caps the short
helix that is C-terminal to it. In the D-loop mutant structure, the position and
orientation of N517 is essentially unchanged, and it still interacts with the
γ-phosphate, backbone of A649 and A651, and N654 side chain (Fig. 6c). Therefore, although the interactions through the D-loop
aspartate side chain are lost
due to mutation to alanine, the
overall D-loop and Walker A positions are essentially unaffected. However, the
B-factors for the D-loop and first turn of the helix that follows it (residues
648–655; 74.9 Å2) are significantly higher than the
whole protomer average for the Walker B/D-loop double mutant
(67.8 Å2), but not the Walker B mutant
(24.2 Å2 for the D-loop versus a whole protomer average
of 34.6 Å2), indicating that aspartate helps rigidify the D-loop region by
acting as a helix cap. Both the global reorganization of the NBD dimer and the
destabilization of the D-loop suggest that the D-to-A mutation in the TAP1 D-loop may impair communication between
the ATPase sites in the NBDs and the peptide-binding site in the TMDs.
Table 2
Data collection and refinement statistics.
Data collection
Space group
C2221
Cell dimensions
a, b, c (Å)
54.26, 123.98, 79.91
α, β, γ
(°)
90, 90, 90
Resolution (Å)
48.98–2.65 (2.74–2.65)*
Rmeas
0.139 (2.89)
I/σI
7.23 (0.58)
Completeness (%)
95.9 (97.5)
Redundancy
3.0 (2.9)
CC(1/2) (%)
99.4 (20.5)
Refinement
Resolution (Å)
48.98–2.65
No. of reflections (test set)
7039 (782)
Rwork/Rfree
24.71/27.02
No. of atoms
Protein
1,930
Ligand/ion
46
Water
20
B-factors
Protein
67.7
Ligand/ion
56.2
Water
52.7
Root-mean-square deviations
Bond lengths (Å)
0.003
Bond angles (°)
0.717
PDB code
4K8O
PDB, Protein Data Bank.
*Values in parentheses are for highest-resolution
shell.
Figure 6
Stable NBD dimer formation and ATP hydrolysis serve as a checkpoint for unidirectional
transport.
(a) Overall alignment of dimers of rat TAP1-NBD Walker B D645N (grey, PDB 2IXE) and Walker B/D-loop
D645N/D651A (cyan) mutants, viewed from the membrane plane (left) or side (right).
The structures are superimposed using the protomer on the left to show the
relative position of the protomer on the right, the cyan arrow showing the change.
D-loops and Walker A motifs are blue and yellow, respectively. (b)
2Fo−Fc electron density map contoured at 1σ
showing the interface of the D-loop from one promoter (light cyan) and Walker A
motif from the second promoter (dark cyan). (c) Detail of the dimer
interface in a including the D-loop aspartate from one protomer and Walker A asparagine from the other protomer. Polar
interactions are highlighted.
We note that our homodimeric TAP1
NBD structure represents only one state within the transport cycle, likely the fully
closed NBD dimer state nearing ATP
hydrolysis. Our structure also bears two copies of the D-loop mutation, unlike the
heterodimeric D674A/wt complex that we observed behaves as a nucleotide-dependent
facilitator. It is therefore possible that functional consequences of the D674A
mutation stem at least in part from yet-to-be observed structural changes in the
heterodimeric closed-NBD assembly and/or other steps in the transport cycle. Recent
structures of a bacterial ABC exporter, TM287/288, provide some evidence for
additional roles of the D-loop in NBD–NBD communication. Nearly identical
structures of a nucleotide-free state and a state with one AMPPNP, bound to the degenerate ATPase site
(root-mean-square deviation of 0.636 Å)36, both retain
D-loop-mediated NBD–NBD contacts. Neither of these structures represents a
fully closed-NBD dimer state, and these D-loop contacts are quite different from the
ones we observed in our TAP1 NBD
dimer.
Discussion
To the best of our knowledge, our study establishes for the first time that TAP (i)
indeed acts as an active transporter pumping peptides against a gradient and (ii)
mechanistically operates as a molecular diode translocating peptides in a strict
unidirectional mode. This formally excludes the possibility that TAP can
retrotranslocate antigens to the cytosol, an important process in cross-presentation
that is essential for the priming of naive cytotoxic T cells37. To define
the vectoriality, the pathway from inward- to outward-facing conformation must differ
from the reverse.Based on our findings we derive the following mechanistic model (Fig.
7): ATP and peptide, which
can bind independently from each other38, trigger a conformational switch
from the inward- to outward-facing conformation39. Peptide release into
the ER triggers ATP hydrolysis, which
is required for disassembly of the NBD dimer driving the outward-facing conformation
back to the inward-facing one. Trans-inhibition takes place if peptide association to
the ER-lumenal low-affinity binding site is faster than the conformational changes from
the outward- into the inward-open state because of the high lumenal peptide
concentration.
Figure 7
Model of the TAP transport cycle: stable NBD dimer formation and ATP hydrolysis serve as a checkpoint for
unidirectional transport.
In the resting state, the TAP NBDs are loaded with ATP. Peptide binding induces a
conformation change (1), which triggers engagement of the NBDs and a
conformational switch into the outward-facing ATP-bound state (2). Peptide release (3) triggers ATP hydrolysis (4), results in
disengagement of the NBDs and restores the inward-facing conformation (5). The
cycle is closed by an ADP/ATP exchange (6). The D-loop mutant can cycle without
hydrolysis or peptide release in the ER lumen (red pathway), leading to a
facilitator phenotype. The inset depicts the energetics of ATP-bound wt TAP (black) and the D674A/wt
mutant (red). A high lumenal peptide concentration causes trans-inhibition of TAP
by saturating an ER-lumenal-binding site, thereby inhibiting step 3.
In the D674A/wt complex (red pathway), the loss of critical H-bonds and higher
flexibility of the D-loop destabilize the NBD dimer and precludes ATP hydrolysis (Fig. 3a).
Thus, NBD dissociation and the subsequent conformational change can occur independently
from ATP hydrolysis and/or peptide
release. Consequently, the inward- and outward-facing conformations can switch back and
forth, leading to an uncoupled bidirectional flow of peptides along their gradient
(Fig. 3). We propose that in wt TAP the dissociation of the
dimer is driven by an intermediate, post-hydrolysis state that is necessarily
incompatible with the dimer—much more so than ADP. The existence of this intermediate step (or rather, the need for
the system to escape it) would impose vectoriality to the process. In the D-loop mutant,
by contrast, association/dissociation is not directionally driven because ATP hydrolysis cannot occur. The D674A complex
returns to the resting state by the reversal of the forward reaction and can therefore
shuttle peptides in both directions. Therefore, the D-loop serves as one of likely
several elements that contribute to vectoriality. Based on the principle of
‘microscopic reversibility’, the wt transport system should, in theory,
run in the opposite direction at a very high lumenal-to-cytosolic peptide, high
ADP and inorganic phosphate
concentrations. However, we did not observe this in our experiments, suggesting that
this pathway is kinetically disfavoured and TAP is arrested by trans-inhibition at high
lumenal peptide concentrations. These findings present a prime example of kinetic versus
thermodynamic control and of the mechanistic link between unidirectional, primary active
ABC transporters and bidirectional, passive facilitators.
Methods
Functional assays
Baculovirus expression of TAP1 and
TAP2 in Sf9 insect cells
(Life Technologies), membrane preparation, solubilization, purification,
reconstitution, peptide binding, peptide translocation and ATPase assays were
performed as described30. D-loop substitutions were introduced in
humanTAP1 and TAP2 by standard cloning procedures. To
analyse ATP binding, purified TAP
was incubated with 8-azido-[α32P]ATP (1 μM) and
MgCl2 (1 mM)
for 5 min at 4 °C in standard buffer (20 mM HEPES, 140 mM NaCl, 15% glycerol, 0.05% digitonin, pH 7.4). After photo-crosslinking for 5 min,
subunits of the TAP complex were analysed by SDS–PAGE (6%) and subsequent
autoradiography was done. TAP2 was
fused N-terminally to tapasin to
allow for separation of both TAP subunits40. The antigen-processing
pathway and MHC I surface expression was reconstituted by coexpression of the
tapasin, HLA-B*4402 and
TAP1/2 in Sf9 insect
cells using baculovirus expression system41. The MHC I surface
expression was analysed by flow cytometry using the conformation-specific
anti-HLA-A/B/C antibody (W6/32) coupled to phycoerythrin (BioLegend). Monoclonal
antibodies used for blots were anti-TAP1 mAb 148.3 (ref. 42),
anti-TAP2 mAb 435.3 (ref.
43) and anti-tapasin mAb 7F6 (ref. 44).
Peptide translocation in proteoliposomes
Purified TAP was reconstituted into liposomes of Escherichia coli polar lipids
and 1,2-dioleoyl-sn-glycero-3-phosphocholine (70/30%) as
described30. Proteoliposomes containing a lipid-to-TAP (w/w) ratio
of 20 were incubated in transport buffer (20 mM HEPES, 140 mM NaCl, 3 mM MgCl2, 5% glycerol, pH 7.4) with indicated
concentrations of the peptide RRYQNSTC(FL488 or AT633)L or
RRYC(FL488)NSTEL32 in the presence or absence of
ATP (3 mM) at
37 °C in a volume of 50 μl. Peptide transport was stopped by
adding ice-cold stopping buffer (10 mM EDTA in phosphate-buffered saline) containing 100-fold molar
excess of unlabelled peptide RRYQKSTEL to prevent peptide binding to TAP.
Proteoliposomes were washed twice by centrifugation for 15 min at
125,000g at 4 °C. In the case of two consecutive transport
periods, the first translocation period was performed with peptide
RRYQNSTC(AT565)L. After intensive washing of proteoliposomes, a
second transport period was conducted with peptide RRYQNSTC.(FL448)L.
To determine the encapsulated volume of liposomes, 50 μM of
5(6)-carboxyfluorescein was added during the swelling of the lipid film and kept
constant during the entire reconstitution procedure.
Crystallization, data collection and refinement
RatTAP1 NBDs were expressed and
purified as before17. Briefly, the proteins were expressed in E.
coli BL21(DE3), affinity-purified on Ni-NTA resin (Qiagen), eluting with an
imidazole step gradient. Fractions containing the NBD were further purified on a
Superdex200 column (GE Healthcare). All mutations were introduced by using QuikChange
mutagenesis kit (primers for D645N:
5′-CTTATCTTGGACAATGCCACCAGTGC-3′ and
5′-CAGGGCACTGGTGGCATTGTCCAAGA-3′; primers for
D651A: 5′-CCAGTGCCCTGGCTGCTGGCAACCAGCTACGGGTC-3′ and
5′-CTGGTTGCCAGCAGCCAGGGCACTGGTGGCATCGTC-3′) and
confirmed by DNA sequencing. RatTAP1 NBD D645N/D651A
(15 mg ml−1) was crystallized at
4 °C in 1+1 μl sitting drops by vapour diffusion against
reservoir solution (0.84 M Na3
citrate, 100 mM Tris, pH 8.0, 3.6 mM NiCl2). Crystals were frozen in reservoir solution
plus 25% glycerol. Diffraction
data were collected at Advanced Photon Source (APS) beamline 24-ID-C (NE-CAT, Argonne
National Labs) and processed with X-ray Detector Software (XDS)45.
Structure was determined by molecular replacement with PHASER46 using
ratTAP1-NBD (D645N; 2IXE) with
nucleotide removed as the search model. Model building and refinement were done with
PHENIX47 and Coot46. Morph movie was made with the
molmovdb.org server48. Figures were made in PyMOL (Schrödinger,
LLC).
Analytical ultracentrifugation
Protein samples (33 μM) dialysed against sample buffer (20 mM
Tris, pH 8.0, 50 mM
NaCl, 5 mM MgCl2) in the presence of the
indicated nucleotide. Experiments were performed in an Optima XL-I analytical
ultracentrifuge equipped with interference optics (Beckman Coulter) using an
eight-hole An-50 Ti rotor (Beckman Coulter), and interference scans were acquired
every 9 min. Buffer density, viscosity and partial specific volumes were
estimated using SEDNTERP49. Sedimentation velocity experiments were
run at 40,000 r.p.m. at 10 °C for 14 h in double sector
cells with sapphire windows. Data were analysed according to continuous sedimentation
coefficient distribution (c(S)) model in Sedfit50, to determine
sedimentation coefficients for each sample. Sedimentation equilibrium experiments
were performed at 12,000, 15,000 and 22,000 r.p.m. at 10 °C in
six-sector cells using three different concentrations (3, 11 and 33 μM)
of each sample or sample buffer containing the indicated nucleotide. After
24 h, samples reached equilibrium and ten interference spectra were recorded.
Data were analysed according to the monomer-dimer self-association model in
SedPhat51. The convergence of data fitting to a global minimum was
verified using different methods including Simplex, Marquardt-Levenberg and Simulated
Annealing.
TAP1-NBD ATP hydrolysis
ATP hydrolysis assays were performed as described41, except
TAP1-NBD protein samples were
stripped of bound nucleotide by passing twice through a PD-10 column equilibrated
with ATPase reaction buffer (150 mM potassium acetate, 10% glycerol, 1 mM dithiothreitol and 50 mM K-HEPES (pH 7.5)) and the
A260/A280 ratio was verified to be <0.6. Data were
collected on a FlexStation 3 (Molecular Devices).
TAP1-NBD nucleotide
binding
Nucleotide-stripped TAP1-NBD
samples were re-concentrated to ~100 μM, and used to make a
series of eight twofold dilutions in assay buffer (20 mM Tris, pH 8.0, 50 mM NaCl, 1 mM dithiothreitol) with 1 μM
ATP-Bodipy (Invitrogen). A background control contained no protein. For competitive
binding experiments, NBDs (25 μM final) were mixed with
1 μM ATP-Bodipy and a series of ten twofold dilutions of unlabelled
nucleotide, with samples with no labelled nucleotide serving as background control.
Fluorescence polarization was measured in FlexStation 3 with excitation at
488 nm. All samples were run two or three times in triplicates. Data were
analysed with Origin (OriginLab Corp.). Binding affinities of unlabelled nucleotides
(Kis) were obtained using
Ki=IC50/([L]/Kd+1).
Author contributions
N.G., R.A. and R.T. performed all experiments with the full-length TAP complex. A.S.V.
and R.G. carried out all experiments with the NBDs of TAP. S.H. constructed the Tsn-TAP
fusion construct. R.A., R.G. and R.T. designed the experiments, N.G., A.S.V., R.A., R.G.
and R.T. analysed the data and wrote the paper.
Additional information
Accession codes: The atomic coordinates and structure factors for the ratTAP1 NBD D645N/D651A structure
have been deposited under accession code 4K8O in the
Protein Data Bank.How to cite this article: Grossmann, N. et al. Mechanistic determinants of
the directionality and energetics of active export by a heterodimeric ABC transporter.
Nat. Commun. 5:5419 doi: 10.1038/ncomms6419 (2014).
Authors: Christoph Baldauf; Susanne Schrodt; Meike Herget; Joachim Koch; Robert Tampé Journal: Proc Natl Acad Sci U S A Date: 2010-05-03 Impact factor: 11.205
Authors: Paul C Smith; Nathan Karpowich; Linda Millen; Jonathan E Moody; Jane Rosen; Philip J Thomas; John F Hunt Journal: Mol Cell Date: 2002-07 Impact factor: 17.970
Authors: Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read Journal: J Appl Crystallogr Date: 2007-07-13 Impact factor: 3.304
Authors: Tina Zollmann; Gemma Moiset; Franz Tumulka; Robert Tampé; Bert Poolman; Rupert Abele Journal: Proc Natl Acad Sci U S A Date: 2015-02-02 Impact factor: 11.205
Authors: Andreas Hinz; Johanna Jedamzick; Valentina Herbring; Hanna Fischbach; Jessica Hartmann; David Parcej; Joachim Koch; Robert Tampé Journal: J Biol Chem Date: 2014-10-15 Impact factor: 5.157
Authors: Anne Nöll; Christoph Thomas; Valentina Herbring; Tina Zollmann; Katja Barth; Ahmad Reza Mehdipour; Thomas M Tomasiak; Stefan Brüchert; Benesh Joseph; Rupert Abele; Vincent Oliéric; Meitian Wang; Kay Diederichs; Gerhard Hummer; Robert M Stroud; Klaas M Pos; Robert Tampé Journal: Proc Natl Acad Sci U S A Date: 2017-01-09 Impact factor: 11.205
Authors: Muhammad Imran Sohail; Diethart Schmid; Katrin Wlcek; Matthias Spork; Gergely Szakács; Michael Trauner; Thomas Stockner; Peter Chiba Journal: Mol Pharmacol Date: 2017-08-07 Impact factor: 4.436
Authors: P Andrew Chong; Patrick J Farber; Robert M Vernon; Rhea P Hudson; Anthony K Mittermaier; Julie D Forman-Kay Journal: J Biol Chem Date: 2015-07-06 Impact factor: 5.157